We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.7%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.4B
AUM Growth
+$86M
(+6.5%)
Cap. Flow
+$66.5M
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
43.74%
Holding
273
New
22
Increased
112
Reduced
84
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Preferred and Income Securities ETF
PFF
|
+$70.7M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$56.5M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$17.4M |
| 4 |
Biogen
BIIB
|
+$8.43M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$8.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck High Yield Muni ETF
HYD
|
+$39.9M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$25.8M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$20M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$17M |
| 5 |
Medtronic
MDT
|
+$9.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.46% |
| 2 | Healthcare | 7.25% |
| 3 | Industrials | 6.27% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Financials | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAC
251
DELISTED
AAC Holdings
AAC
| $41K | ﹤0.01% |
60,454
+45,454
| +303% | +$37.9K |
|
252
Lloyds Banking Group
LYG
$90.7B
| $39K | ﹤0.01% |
14,879
| – | – |
|
|
AVEO
253
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $19K | ﹤0.01% |
2,260
| – | – |
|
|
EXAS
254
DELISTED
Exact Sciences
EXAS
| – | – |
-1,700
| Closed | -$201K |
|
|
255
VanEck High Yield Muni ETF
HYD
$4.44B
| – | – |
-625,021
| Closed | -$39.9M |
|
256
Safety Insurance
SAFT
$1.51B
| – | – |
-2,250
| Closed | -$214K |
|
257
Constellation Brands
STZ
$22.3B
| – | – |
-1,192
| Closed | -$235K |
|
258
Valero Energy
VLO
$92.6B
| – | – |
-2,660
| Closed | -$228K |
|
|
259
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
| – | – |
-617,143
| Closed | -$17M |
|
|
ARRY
260
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-14,000
| Closed | -$649K |
|
|
FM
261
DELISTED
iShares Frontier and Select EM ETF
FM
| – | – |
-16,158
| Closed | -$479K |
|
|
UBNK
262
DELISTED
UNITIED FINANCIAL BANCORP INC
UBNK
| – | – |
-10,800
| Closed | -$153K |
|
Similar funds
DWM
ANTB
VCM
ACM
AG
KCM
SCM
ASC
Grimes & Company's Q3 2019 Portfolio in Review
As of Q3 2019, Grimes & Company held 273 positions worth $1.4B, up 6.5% from $1.32B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Grimes & Company deployed $66.5M of net new capital in Q3 2019, opening 22 new positions and adding to 112 existing holdings. Its largest new stake was iShares Preferred and Income Securities ETF: 1,900,093 shares worth $71.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $25.8M trimmed.
- Grimes & Company's largest Q3 2019 buy was iShares Preferred and Income Securities ETF: 1,900,093 shares worth $71.3M.
- Grimes & Company added most to iShares 0-1 Year Treasury Bond ETF in Q3 2019, an estimated $56.5M increase.
- Grimes & Company's biggest Q3 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $25.8M.
- Grimes & Company fully exited VanEck High Yield Muni ETF in Q3 2019, selling an estimated $39.9M.
- Grimes & Company's ten largest holdings make up 44% of its $1.4B portfolio in Q3 2019.
- Grimes & Company opened 22 new positions and closed 14 in Q3 2019.
- Grimes & Company's portfolio value rose 6.5% quarter-over-quarter to $1.4B.
Based on Grimes & Company's 13F filing for Q3 2019, filed 5 Nov 2019.